Insulin initiation and titration for people with type 2 diabetes managed in primary care and guided by continuous glucose monitoring

医学 初级保健 2型糖尿病 连续血糖监测 内科学 胰岛素 糖尿病 重症监护医学 内分泌学 滴定法 血糖自我监测 2型糖尿病 胰腺激素
作者
Ramzi Ajjan,Tadej Battelino,Xavier Cos,Stefano Del Prato,Chantal Mathieu,Mohammed S. Almehthel,Jochen Seufert,Bruno Guerci,Samuel Seidu
出处
期刊: [Elsevier BV]
卷期号:2 (8): 100193-100193
标识
DOI:10.1016/j.lanprc.2026.100193
摘要

The global burden of diabetes is projected to reach 1·31 billion people by 2050, the majority of whom will have type 2 diabetes (T2D). There are considerable regional and socioeconomic inequities in access to care for people with T2D, and providing care for such a large number of individuals will require changes to current management approaches. Chronic hyperglycaemia directly contributes to premature morbidity and mortality while impairing quality of life. Therefore, timely intervention to improve hyperglycaemia will reduce long-term complications and spiralling diabetes health-care costs. However, treatment inertia is common, particularly with insulin initiation and titration, related to the complexities involved and concerns over hypoglycaemia. This inertia is particularly true for people with T2D managed in primary health care. The increasing use of continuous glucose monitoring (CGM) systems has enabled more effective management of individuals with diabetes, including timely initiation and titration of insulin therapy for people with T2D, typically started as basal insulin. As CGM metrics can safely and effectively guide health-care professionals and individuals with diabetes to refine insulin treatment, practical guidance on how to best apply this information in clinical practice is needed. In this Viewpoint, we propose practical algorithms for using well established CGM metrics in the management of basal-insulin initiation, titration, and intensification, as well as in the process of insulin deintensification. The collective aim of this expert guidance is to optimise glycaemia by not only lowering high glucose levels, but also minimising hypoglycaemia to improve outcomes and quality of life for individuals with T2D.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
无情的访风完成签到,获得积分10
1秒前
墨染完成签到,获得积分10
1秒前
O基米德完成签到 ,获得积分10
2秒前
2秒前
ChaseY完成签到 ,获得积分10
2秒前
orixero的应助被苗惜霜采纳,获得10
2秒前
liangliang完成签到,获得积分10
2秒前
3秒前
1618完成签到 ,获得积分10
3秒前
luxx完成签到,获得积分10
4秒前
鱼羊完成签到,获得积分10
4秒前
fantasy的应助被高贵土豆采纳,获得10
5秒前
无花果的应助被Believer采纳,获得10
5秒前
zoey发布了新的文献求助10
5秒前
STAR完成签到 ,获得积分10
5秒前
雷家完成签到,获得积分10
5秒前
FightingW完成签到,获得积分10
6秒前
6秒前
pp完成签到,获得积分10
6秒前
7秒前
Ppao7ii完成签到,获得积分10
7秒前
洋洋洋完成签到 ,获得积分10
8秒前
9秒前
CarryLJR发布了新的文献求助10
9秒前
尝原完成签到,获得积分10
9秒前
小蘑菇的应助被plj采纳,获得10
9秒前
maoning完成签到,获得积分10
9秒前
端庄幻桃发布了新的文献求助10
10秒前
10秒前
jyxm发布了新的文献求助10
10秒前
su完成签到 ,获得积分10
11秒前
11秒前
11秒前
12秒前
梅西完成签到,获得积分10
13秒前
13秒前
13秒前
曹梓聪发布了新的文献求助10
13秒前
mlg1552003发布了新的文献求助10
13秒前
刘晨发布了新的文献求助10
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175534
求助须知:如何正确求助?哪些是违规求助? 9567220
关于积分的说明 21791292
捐赠科研通 7770111
什么是DOI,文献DOI怎么找? 3431868
关于科研通互助平台的介绍 2556244
邀请新用户注册赠送积分活动 2477299